Analysis of MarketScan Data for Immunosuppressive Conditions and Hospitalizations for Acute Respiratory Illness, United States

Analysis of MarketScan Data for Immunosuppressive Conditions and Hospitalizations for Acute Respiratory Illness, United States

Increasing use of immunosuppressive biologic therapies poses a challenge for infectious diseases. Immunosuppressed patients have a high risk for influenza complications and an impaired immune response to vaccines. The total burden of immunosuppressive conditions in the United States, including those...

Full description

Bibliographic Details
Main Authors: Manish Patel, Jufu Chen, Sara Kim, Shikha Garg, Brendan Flannery, Zaid Haddadin, Danielle Rankin, Natasha Halasa, H. Keipp Talbot, Carrie Reed
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2020-08-01
Series:Emerging Infectious Diseases
Subjects:
immunosuppressive conditions
biologics
cancer
influenza
respiratory infections
acute respiratory illness
Online Access:https://wwwnc.cdc.gov/eid/article/26/8/19-1493_article

Internet

https://wwwnc.cdc.gov/eid/article/26/8/19-1493_article

Similar Items